<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

qz
Eli Lilly's diabetes drug wins FDA approval to lower heart attack and stroke risk

The diabetes drug, already the top-prescribed branded type 2 diabetes medicine in the U.S., showed an 8% lower rate of major heart events than Lilly's older drug Trulicity [...]

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
Facebook scammers want you to think Elon Musk can cure diabetes

Elon Musk discovered a simple 30-second “fridge trick” that can reverse diabetes, but the discovery has spooked pharmaceutical companies so much they put a $78 million bounty on his head, forcing [...]

Match Score: 149.89

Destination
How to use the AirPods Pro 3’s heart rate tracking feature

Your AirPods may soon become your most important pieces of fitness gear. One of the AirPods Pro 3’s new features is heart rate tracking for both workouts and periodic pulse checks. Apple’s latest [...]

Match Score: 130.50

Destination
Eli Lilly signs $2.75 billion deal with AI drug developer Insilico Medicine

US pharmaceutical giant Eli Lilly is betting big on AI-driven drug development, signing a $2.75 billion deal with Hong Kong-listed Insilico Medicine.<br /> The article Eli Lilly signs $2.75 bill [...]

Match Score: 87.74

Destination
Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study

Eli Lilly’s (LLY) and Novo Nordisk’s (NVO) weight loss drugs went head-to-head in a weight loss study for the first time — and Eli Lilly’s drug came out on top.Read more... [...]

Match Score: 84.18

Destination
Eli Lilly's online health platform just expanded beyond weight loss to tackle Alzheimer’s

Just about a year after launching a direct-to-consumer online platform to sell treatments for diabetes and obesity, Eli Lilly (LLY) is now expanding the program to offer resources for Alzheimer’s d [...]

Match Score: 76.15

qz
Eli Lilly's experimental diabetes drug cuts weight by 17% in study

Eli Lilly's experimental drug retatrutide helped Type 2 diabetes patients lose up to 16.8% of their body weight in a Phase 3 trial, topping all rivals. [...]

Match Score: 72.64

Destination
Eli Lilly and Novo Nordisk are tackling heart health next

After revolutionizing the weight-loss drug market, Novo Nordisk (NVO) and Eli Lilly (LLY) are setting their sights on heart health.Read more... [...]

Match Score: 70.10

Destination
An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup

An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as it would be easier to manufacture and distribute globally. Three U.S. sen [...]

Match Score: 68.56

Destination
Beats Powerbeats Pro 2 review: Apple's first earbuds with heart-rate tracking

The Powerbeats Pro 2 ($250) was hardly a secret. Although Beats officially announced the new fitness-focused earbuds today, it has been teasing them since last September. And over the last few weeks, [...]

Match Score: 68.27